Total submissions: 17
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000039380 | SCV000063064 | benign | not specified | 2008-12-05 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000039380 | SCV000153044 | benign | not specified | 2015-02-10 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000204535 | SCV000261412 | benign | Arrhythmogenic right ventricular dysplasia 5 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000039380 | SCV000314285 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV000241696 | SCV000319069 | benign | Cardiovascular phenotype | 2015-05-13 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000769154 | SCV000900528 | benign | Cardiomyopathy | 2015-10-22 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000769154 | SCV000910607 | benign | Cardiomyopathy | 2018-03-08 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV001529532 | SCV001157054 | benign | not provided | 2023-11-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001529532 | SCV001938107 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001529532 | SCV002544769 | benign | not provided | 2024-06-01 | criteria provided, single submitter | clinical testing | TMEM43: BP4, BP7, BS1, BS2 |
Fulgent Genetics, |
RCV002490538 | SCV002795075 | likely benign | Arrhythmogenic right ventricular dysplasia 5; Emery-Dreifuss muscular dystrophy 7, autosomal dominant; Auditory neuropathy, autosomal dominant 3 | 2021-10-05 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000204535 | SCV004841480 | benign | Arrhythmogenic right ventricular dysplasia 5 | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001529532 | SCV001743124 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000039380 | SCV001921070 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000039380 | SCV001932449 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000039380 | SCV001958015 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000039380 | SCV001971411 | benign | not specified | no assertion criteria provided | clinical testing |